No photo of Erkki Rintala
  • Finland

19992016
If you made any changes in Pure these will be visible here soon.

Publications 1999 2016

2016

Intravesical Bacillus Calmette-Guerin Versus Combination of Epirubicin and Interferon-alpha 2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study

Marttila, T., Järvinen, R., Liukkonen, T., Rintala, E., Bostrom, P., Seppänen, M., Tammela, T., Hellstrom, P., Aaltomaa, S., Leskinen, M., Raitanen, M. & Kaasinen, E., 2016, In : European Urology. 70, 2, p. 341-347 7 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder

Kaasinen, E., Wijkstrom, H., Rintala, E., Mestad, O., Jahnson, S. & Malmstrom, P-U., Oct 2016, In : Scandinavian Journal of Urology. 50, 5, p. 360-368 9 p.

Research output: Contribution to journalArticleScientificpeer-review

2015

Long-term Outcome of Patients with Frequently Recurrent Non-muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guerin (BCG) or Alternating BCG and Interferon-alpha 2b Instillations: Prospective Randomised FinnBladder-4 Study

Jarvinen, R., Marttila, T., Kaasinen, E., Rintala, E., Aaltomaa, S., Kallio, J., Liukkonen, T., Puolakka, V-M., Seppanen, M., Tuhkanen, K., Vaarala, M., Viitanen, J., Bostrom, P. J. & Grp, F., 1 Oct 2015, In : European Urology. 68, 4, p. 611-617 7 p.

Research output: Contribution to journalArticleScientificpeer-review

Reply from Authors re: Robert S. Svatek. Long-term Outcomes of the FinnBladder-4 Study. Eur Urol 2015;68:618-9 Which Type of Maintenance Matters?

Jarvinen, R., Kaasinen, E., Marttila, T., Rintala, E. & Bostrom, P., 1 Oct 2015, In : European Urology. 68, 4, p. 619-620 2 p.

Research output: Contribution to journalArticleScientific

Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer

Rosenblatt, R., Sherif, A., Rintala, E., Wahlqvist, R., Ullen, A., Nilsson, S., Malmstrom, P-U. & Nordic Urothelial Canc Grp, 2012, In : European Urology. 61, 6, p. 1229-1238 10 p.

Research output: Contribution to journalArticleScientificpeer-review

2011

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

Med Res Council Adv Bladder Canc, Club Urologico Espanol Tratamiento, Norwegian Bladder Canc Study Grp, Finnbladder & Rintala, E. J., 2011, In : Journal of Clinical Oncology. 29, 16, p. 2171-2177 7 p.

Research output: Contribution to journalArticleScientificpeer-review

2010

Virtsateiden kasvaimet

Rintala, E. J., 2010, Kirurgia. Roberts, P. J., Aarnio, P., Höckerstedt, K. & Leppäniemi, A. (eds.). 2. uud. p. ed. Helsinki: Kustannus Oy Duodecim, p. 841-858 18 p.

Research output: Chapter in Book/Report/Conference proceedingChapterProfessional

2002

Chorionic gonadotropin -subunit and core fragment in bladder cancer; mRNA and protein expression in urine, serum or tissue

Hotakainen, K., Haglund, C. H., Paju, A. P., Nordling, F. S. A., Alfthan, H. V., Rintala, E. J. & Stenman, U. H. E., 2002, In : European Urology. 103, p. 677-685 9 p.

Research output: Contribution to journalArticleScientificpeer-review